Hashimoto Yosuke, Shimada Yutaka, Kawamura Junichiro, Yamasaki Seiji, Imamura Masayuki
Department of Surgery and Surgical Basic Science, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Oncology. 2004;67(3-4):262-70. doi: 10.1159/000081327.
Fascin, an actin-bundling protein that is found in membrane ruffles, microspikes, and stress fibers, induces membrane protrusions and increases cell motility in various transformed cells. The expression of fascin in epithelial neoplasms has been described only recently, and its role in gastric cancer is still unknown.
Paraffin sections of gastric carcinoma from 214 patients were immunohistochemically investigated using monoclonal antifascin antibody. Staining more than 5% of tumor cells was recorded as positive immunoreactivity.
Overall, fascin immunoreactivity was detected in 54 out of a total of 214 patients (25%). 26 patients were classified as 1+ (5-25% immunoreactive tumor cells) and 28 were 2+ (>25%). In these patients, 7 tumors showed high (>75%) fascin immunoreactivity. Increased immunoreactivity of fascin was sometimes seen at the edge of the tumor. Fascin immunoreactivity was increased according to the extent of primary tumor (p = 0.026). Fascin expression was correlated with age (p = 0.005), serosal invasion (p = 0.013), positive lymph node metastasis (p = 0.006), histopathological grading (p = 0.019), TNM stage (p = 0.003) and recurrence (p = 0.006); however, it was not correlated with distant metastasis (p = 0.108), Lauren's type (p = 0.205), or R classification (p = 0.056). Among 166 patients with T1, T2, T3 or T4, those with fascin-positive tumors had a significantly poorer prognosis than those with fascin-negative tumors (p = 0.029). Multivariate analysis showed that fascin expression was not an independent poor prognostic factor.
Our findings suggest that the immunohistochemical detection of fascin could provide useful information as one of the prognostic factors in gastric cancer patients.
Fascin是一种肌动蛋白捆绑蛋白,存在于膜皱褶、微刺和应力纤维中,可诱导膜突出并增加各种转化细胞的细胞运动性。Fascin在上皮肿瘤中的表达直到最近才被描述,其在胃癌中的作用仍不清楚。
使用单克隆抗Fascin抗体对214例胃癌患者的石蜡切片进行免疫组织化学研究。肿瘤细胞染色超过5%被记录为阳性免疫反应。
总体而言,214例患者中有54例(25%)检测到Fascin免疫反应。26例患者被分类为1+(免疫反应性肿瘤细胞为5%-25%),28例为2+(>25%)。在这些患者中,7个肿瘤显示出高(>75%)Fascin免疫反应性。Fascin免疫反应性有时在肿瘤边缘增加。Fascin免疫反应性根据原发肿瘤范围增加(p = 0.026)。Fascin表达与年龄(p = 0.005)、浆膜侵犯(p = 0.013)、阳性淋巴结转移(p = 0.006)、组织病理学分级(p = 0.019)、TNM分期(p = 0.003)和复发(p = 0.006)相关;然而,它与远处转移(p = 0.108)、劳伦分型(p = 0.205)或R分类(p = 0.056)无关。在166例T1、T2、T3或T4患者中,Fascin阳性肿瘤患者的预后明显比Fascin阴性肿瘤患者差(p = 0.029)。多变量分析表明,Fascin表达不是一个独立的不良预后因素。
我们的研究结果表明,Fascin的免疫组织化学检测作为胃癌患者的预后因素之一,可以提供有用的信息。